Angelica Peebles

Angelica Peebles

Former Journalist

Latest

Depressed unrecognizable mother looks out window while holding baby

A New Pill for Postpartum Depression Brings New Hope

August 10, 2023

August 10, 2023

A New Pill for Postpartum Depression Brings New Hope

Depressed unrecognizable mother looks out window while holding baby

August 9, 2023

August 9, 2023

Illumina Slides After Slashing Full-Year Forecast

Testing Inside a Genome Sequencing Lab as India to Scale Up Omicron Scrutiny

August 9, 2023

August 9, 2023

A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients

Bluebird Bio’s Zynteglo could cure beta thalassemia, yet some older people with the disease say they have faced difficulties in trying to get treated

A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients

August 4, 2023

August 4, 2023

Sage Tumbles as FDA Narrows Depression Pill’s Approval

FRANCE-HEALTH-VIRUS-MATERNITY

August 3, 2023

August 3, 2023

Moderna Raises Covid Shot Sales Guidance on Japan, US Pacts

Moderna

July 24, 2023

July 24, 2023

Biotech Wins Fail to Move Stock Indicators Ahead of Earnings

Lab

July 18, 2023

July 18, 2023

Should I worry about mosquito bites?

FRANCE-ANIMAL-INSECT-MOSQUITO

July 17, 2023

July 17, 2023

BridgeBio Surges After Heart Drug Succeeds in Pivotal Trial

Laboratory

July 14, 2023

July 14, 2023

Lilly to Pay Up to $2 Billion for Obesity Startup Versanis

Lilly Gains As Therapy Slows Alzheimer's Disease In Study

July 11, 2023

July 11, 2023

EU Set to Hit Illumina With Fine on Wednesday Over Grail Deal

Cirina Ltd. Co-Founder Dennis Lo Interview and Operations at a Chinese University of Hong Kong Cancer Research Facility

June 28, 2023

June 28, 2023

Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep

General Views Of The Catalent Company Headquarter

June 22, 2023

June 22, 2023

FDA Clears First Gene Therapy for Kids’ Deadly Muscle Disease

June 21, 2023

June 21, 2023

A New Company Looks for Culprits Behind Infections

A New Company Looks for Culprits Behind Infections

June 20, 2023

June 20, 2023

A Startup Is Getting $35 Million to Find Culprits Behind Brain Infections

A Startup Is Getting $35 Million to Find Culprits Behind Brain Infections

June 12, 2023

June 12, 2023

Illumina’s Sudden CEO Exit Is Just One of Many Problems Facing DNA Company

The sudden resignation of Francis deSouza raises questions about the firm’s future after its proxy fight with Carl Icahn.

Illumina’s Sudden CEO Exit Is Just One of Many Problems Facing DNA Company

June 1, 2023

June 1, 2023

Families Fight for a Muscular Dystrophy Drug’s Approval

US-HEALTH-VIRUS-EDUCATION

May 24, 2023

May 24, 2023

Sarepta Tumbles as FDA Delays Duchenne Gene Therapy Decision

Sarepta Therapeutics Inc

May 10, 2023

May 10, 2023

Sarepta’s Gene Therapy Benefits Are Unclear, FDA Staff Says

Biotech Investor Sees Covid-19 Drug Shaking Off Company’s Tarnished Past

May 4, 2023

May 4, 2023

Biogen’s CEO Says He Doesn’t Want ‘Whole Portfolio of Moonshots’

Christopher Viehbacher will consider acquisitions to expand the company’s focus beyond difficult brain diseases like Alzheimer’s and Parkinson’s.

Biogen’s CEO Says He Doesn’t Want ‘Whole Portfolio of Moonshots’